Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMH as Predictor of Clomiphene Response in PCOS
NCT03316469Unknown
- Sponsor
- Ain Shams University
- Start
- Jul 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
01
Overview
Open-label trial of clomiphene in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Ain Shams University. Primary endpoint: AMH in prediction of Ovulation in women with PCOS at 10 days. Status: unknown.
02
Drugs
clomiphene
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03316469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03316469.